Navigation Links
Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
Date:6/30/2008

chiatric monitoring); patients taking sedatives, hypnotics, or other psychoactive drugs; and in elderly patients, pregnant patients, nursing mothers, or pediatric patients.

The most common adverse effects probably related to dronabinol are dizziness, euphoria, paranoid reaction, somnolence, abnormal thinking, abdominal pain, nausea and vomiting.

Please read full prescribing information available at http://www.parpharm.com/products.

About Par Pharmaceutical

Par Pharmaceutical, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit http://www.parpharm.com.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward- looking and, as such, are subject to risks and uncertainties, including the extent and impact of litigation arising out of the accounting issues described in the Company's filings with the Securities and Exchange Commission (SEC), the difficulty of predicting FDA filings and approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, uncertainty of patent litigation filed against the Company, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks and uncertainties detailed from time to time in the Company's filings with the SEC, such as the Company's reports on Form 10-K, Form 10-Q and Form 8-K, and amendments thereto. Any forward-looking statements included
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Sigma-AldrichCorporat...nferenceonTuesday,December1stat1:45PMGMTinLondon,7...broadcastovertheInternetavailableat http://inve ...e"Webcast"icontoaccessthisfile. ,, AboutSigma...ghTechnologycompany.Itschemicalandbiochemicalprodu...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedth...approvedthe,investigationalnewdrugapplication(IND)...linformulationtotreatdiabetes.ThisIND,approvalallo..., Diabetesisadisordercharacteristicofhighbloodg...softenresultinseveremicro-and,macro-vasculardiseas...
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,N...company,today,announcedthatithassubmittedaMAAtothe...mpany,senzymereplacementtherapyindevelopment,forth...eting,applicationforvelaglucerasealfathathasbeensu...ndCanada. , Basedonaglobalsupplyshortageofthe...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the glob...ina,s patent office is now the world,s leading pro...y. China trailed Japan,s patent office, the World ... United States Patent and Trademark Office (USPTO)...005, WIPO in 2006, and exceeded Japan for the firs...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
... Wis. - Acknowledging that a return to profitabil...lthcare reported an annual net loss of $258.5 mil...006 that saw several executives resigned in the wa...ch included a goodwill impairment, trade name impa..., or $6.85 per share, compares to a net loss of $2...
...s. - State Senator Robert Cowles admitted his c...he worst news about the state of Wisconsin,s infor...ut in anticipation of the Legislative Audit Burea...colleague and a software executive, isn`t sure the...on is that the audit on state IT projects should b...
...rted this column just over four years ago, I had n...ar. My interest in writing a column was to share w...unity information that I thought would help them w...l awareness about life science in the Midwest. , ...ed that I couldn,t afford the kind of market resea...
Other Biology Technology:Merge Healthcare suffers $258M loss in `06 2Is the worst over for state technology failures? 2A Midwest life-science odyssey comes full circle 2A Midwest life-science odyssey comes full circle 3A Midwest life-science odyssey comes full circle 4A Midwest life-science odyssey comes full circle 5A Midwest life-science odyssey comes full circle 6A Midwest life-science odyssey comes full circle 7A Midwest life-science odyssey comes full circle 8
(Date:11/23/2009)...iated strain of the deadly superbug MRSAan infecti...ioticsposes a far greater health threat than previ...according to a study in the December issue of Eme... easily picked up in fitness centers, schools, and... burden of MRSA within hospitals, the report found...
(Date:11/23/2009)...ests that a common oral bacterium may exacerbate a...et al, "Unique Lipids from a Common Human Bacteriu... Enhancing Autoimmunity," appears in the December ... , Multiple sclerosis (MS), a disease where the ...ffects nearly 1 in 700 people in the United States...
(Date:11/23/2009)...University of Alabama at Birmingham (UAB) research...ng medical conditions (co-morbidity) do not explai...ericans compared to Caucasians who also have colon... Cancer , a journal of the American Cancer Society...co-morbidity are independent predictors of poor su...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2Nepali Home Minister Commends Narconon International for Saving Lives 56495 1Nepali Home Minister Commends Narconon International for Saving Lives 56495 2The Dr Oz Show Names Core Team Oz 56493 1The Dr Oz Show Names Core Team Oz 56493 2The Dr Oz Show Names Core Team Oz 56493 3The Dr Oz Show Names Core Team Oz 56493 4
..., COLD SPRING HARBOR, N.Y. In 1911, the influ...edity in Relation to Eugenics , advancing his idea...h century. It became a college textbook and a fou...e United States. Although the eugenic ideals of t...ejected, many of the issues raised by Davenport ar...
..., In a special supplement to Pediatrics, edited a...Abuse and Alcoholism (NIAAA), physicians will have...f current research on biological, behavioral, and ...ence that foster the initiation, maintenance, and ... youth. This is a first time collection of where ...
..., Neurons grafted into the brain of a patient wit...oped Lewy body pathology, the defining pathology f.... Kordower, PhD, and associates and published in t... suggest that Parkinsons disease is an ongoing pro...in the same way the disease affects host dopamine ...
Other Biology News:Reflecting on the social implications of human genetics research -- past, present and future 2Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 2Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 3Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 4New study shows that fetal cells to treat Parkinson's disease may not function long term 2
...e will give a positive reaction for leukocytes on ...rs are of US origin and have been tested and found...s and HIV-1 Antigen by currently approved FDA meth... USE ONLY IN MANUFACTURING OR RESEARCH. THIS MATER...
... is a dedicated cuff pump for small animal noninva...es manual inflation and can be used for all IITCs ... rat; from single up to multi-channel systems are ...stable cut-off pressure in 50 mmHg increments, adj...
Wiper Dispenser, Enclosed from Terra Universal, Inc.
...t that it uses a deep-UV deuterium bulb, which pro... a shutter (controlled via a TTL signal or switch)...werful, stable output from 215-400 nm. In addition...le, providing a wavelength range of 190-400 nm. Th...
Biology Products: